International Archives of Allergy and Immunology · 2002 · 22 citations · 22 references
Life SciencesImmunologyMolecular BiologyAllergyHypersensitivityMonoclonal AntibodiesAllergic DiseaseAntibody CharacterizationHumoral ImmunityIge-mediated AllergyMonoclonal Antibody TechnologyType I HypersensitivityAntibody Fc Fusion ProteinsFc Fusion Protein ExpressionIge-mediated HypersensitivityIge-mediated ResponsesImmediate Hypersensitivity ReactionsImmunoglobulin E (Ige)Protein Membrane AnchoringType I Hypersensitivity Reactions
BACKGROUND: IgE mediates immediate-type hypersensitivity reactions responsible for various allergic symptoms. It is secreted by IgE-producing plasma cells, which differentiate from B cells expressing membrane-bound IgE (mIgE) on their surface. The epsilon-chain of human mIgE contains a membrane-anchoring peptide and an extra 52-amino-acid (a.a.)-long domain (referred to as C(epsilon)mX) between the membrane anchor and the CH4 domain. OBJECTIVE: The study was designed to evaluate the effects of C(epsilon)mX-specific monoclonal antibodies (mAbs) to target IgE-expressing B cells and decrease IgE production. METHODS: A C(epsilon)mX-containing IgG1.Fc fusion protein was produced in CHO cells and used to immunize mice; five hybridoma clones secreting C(epsilon)mX-specific mAbs were obtained. RESULTS: Characterization of the mAbs using ELISA, immunoprecipitation, and immunoblotting methods showed that they could bind to both native and denatured forms of C(epsilon)mX. The mAbs exhibited mutual inhibition of binding to mIgE. Epitope mapping using synthetic peptides revealed that all five mAbs recognize the same epitope, RADWPGPP, located near the C-terminus of C(epsilon)mX. Binding of one of the mAbs to mIgE on SKO-007 cells induced the cross-linking of mIgE molecules on the cell surface, resulting in their patching and capping. In vitro functional analysis revealed that mAbs are able to cause complement-mediated cytotoxicity on transfectants expressing the Fc portion of mIgE. CONCLUSION: We have prepared several human mIgE-specific mAbs. The potential of the mAbs on targeting mIgE+ B cells was demonstrated by CDC analysis.
22
Maturation of the immune response in germinal centers
Claudia Berek, Ambros Berger, M. Apel · Cell · 1991 · 905 citations
Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
Henry Milgrom, Robert B. Fick, John Q. Su et al. · New England Journal of Medicine · 1999 · 707 citations · Full text